Kewaunee Scientific posts Q4 profit of $0.34/share; FY revenue up 30% to $219.5M

KEWAUNEE SCIENTIFIC CORP /DE/

2023-FY EPS reported $0.25 revenue$219,494,000

Q4 net earnings $1,005,000 ($0.34 diluted EPS) vs net loss of $362,000 ($0.13 loss) in prior year.
Q4 sales $53,986,000, up 8.6% YoY; International segment sales surged 57.3% to $18,863,000.
Full fiscal year 2023 net earnings $738,000 ($0.25 EPS) vs net loss $6,126,000 ($2.20 loss); sales up 30% to $219,494,000.
EBITDA for FY2023 improved to $7,517,000 from $394,000; domestic segment returned to profit.
Backlog at April 30, 2023 was $147.9 million, down from $173.9 million a year ago; cash increased to $13.8 million from $6.9 million.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

KEWAUNEE SCIENTIFIC CORP /DE/ reported financial results for the fourth quarter and fiscal year ended April 30, 2023.

Period: the fourth quarter and fiscal year ended April 30, 2023
Result: reported results

Exact text from the filing

On June 28, 2023, Kewaunee Scientific Corporation issued a press release announcing its financial results for the fourth quarter and fiscal year ended April 30, 2023.

View on SEC.gov

310 earnings releases filed in the last 30 days. Browse all earnings releases →

KEWAUNEE SCIENTIFIC CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000055529-23-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.